RxDoctor Payments DataLook up a doctor →

Nataliya Osorio, NP

Gerontology · Riverside, CANPI 1861009797

Payments from drug & device makers

$13,124in general payments, 2019–2025

Across 539 payments — averaging $24.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Livanova USA, Inc.$3K
  • AbbVie$3K
  • Acadia Pharmaceuticals Inc$1K
  • MDD US Operations, LLC$507
  • Teva Pharmaceuticals USA, Inc.$502
  • Biohaven Pharmaceutical Holding Company Ltd.$487
  • plus $5K from 39 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Livanova USA, Inc.15$2,709
AbbVie(2 entities)156$2,684
Acadia Pharmaceuticals Inc68$1,032
MDD US Operations, LLC38$507
Teva Pharmaceuticals USA, Inc.14$502
Biohaven Pharmaceutical Holding Company Ltd.27$487
Biogen9$480
Argenx US, Inc.19$467
Amneal Pharmaceuticals LLC16$465
SK Life Science, Inc.21$458
Neurocrine Biosciences, Inc.9$270
Lundbeck LLC9$241
Pfizer19$234
Takeda Pharmaceuticals U.S.A., Inc.8$225
Biohaven Pharmaceuticals, Inc.7$209
Novartis15$201
Corium, LLC9$199
AstraZeneca9$198
Otsuka America Pharmaceutical, Inc.9$191
UCB, Inc.5$149
Amgen7$127
Lilly USA, LLC6$112
Sumitomo Pharma America, Inc.5$112
Jazz Pharmaceuticals Inc.3$97
Avanir Pharmaceuticals, Inc.4$81
Ipsen Biopharmaceuticals, Inc3$79
Sunovion Pharmaceuticals Inc.4$75
Supernus Pharmaceuticals, Inc.3$55
CSL Behring2$48
Forte Bio-pharma LLC2$47
Scilex Pharmaceuticals Inc.2$46
Terumo BCT, Inc.2$43
Collegium Pharmaceutical, Inc.2$37
Neurelis, Inc.1$32
GE HealthCare1$31
Upsher-smith Laboratories LLC1$24
Kyowa Kirin, Inc.1$24
Catalyst Pharmaceuticals, Inc.1$23
Avion Pharmaceuticals1$22
Eisai Inc.1$21
Genentech USA, Inc.1$20
Almatica Pharma LLC1$16
Tanabe Pharma America, Inc.1$15
Johnson & Johnson1$14
Xeris Pharmaceuticals, Inc.1$14

How this compares

$13,124 in reported general payments places this provider in the 95th percentile of 348 gerontology providers in California.

See all gerontology providers in California →

Medicare billing

Part B allowed, 2024
$16,429
Medicare patients
110
Services billed
145

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gerontology in Riverside

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →